Search

everythinglearnresearchcommunity

for

Search:↓

Researchers created a fully functional, bioengineered skin system with hair from stem cells that successfully integrated when transplanted into mice.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Scientists successfully created and transplanted bioengineered hair follicles that function like natural ones, suggesting a new treatment for hair loss.

Scientists made working salivary glands in mice using bioengineered cells, which could help treat dry mouth.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Pharmaceutical care in transplantation faces challenges but has promising future opportunities for better outcomes.

Transplant patients often get skin problems, with treatments varying by condition.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

Organ transplant recipients have a higher risk of skin cancer over time, atopic dermatitis skin shows unusual bacterial and fungal patterns, a new tool for measuring hidradenitis suppurativa severity was created, and gene expression changes in male baldness suggest new treatments.

A rare skin condition was confirmed to be associated with a specific virus in a young girl.

The document concludes that transplantology has evolved with improved techniques and materials, making transplants more successful and expanding the types of transplants possible.

Bioprinting could greatly improve health outcomes but faces challenges like material choice and ensuring long-term survival of printed tissues.

New hair regrowth model introduced, imiquimod kills skin cancer cells, T-cadherin loss makes skin cancer more invasive, no strong link between PTCH1 gene and skin cancer after transplant, and male teens more likely to have hereditary hair loss.

New hair regrowth model proposed, imiquimod found to kill skin cancer cells, T-cadherin loss linked to invasive skin cancer, no clear gene link to skin cancer after transplant, and study on children's hair loss shows male dominance and genetic ties.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Cyclosporine A was found to increase hair growth in mouse whisker follicles.

Liver transplant can lead to neurological, pulmonary, cardiovascular, and renal complications, with older patients facing higher risks.

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

Oxygen levels can drop during liver transplant if bypass pressures are too high, but other reasons should be checked first.

Stem cell therapy is a promising approach for hair regrowth despite potential side effects.

New hair transplant methods offer more natural results and better graft survival, with ongoing research to increase donor hair options.

SVF-enhanced adipose transplantation shows potential as a hair loss treatment.

New instruments were introduced to make hair transplantation surgery more precise and improve graft survival.

Robotic hair transplantation with AI offers more reliable, precise, and efficient hair restoration.

MSC-Exos can aid organ development and offer therapeutic benefits for various conditions.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Uterine transplants for transgender women are feasible but need more research.

Scaffold-based strategies show promise for regenerating hair follicles and teeth but need more research for clinical use.

Some patients developed hair loss after islet cell transplant possibly due to their immune-suppressing medications.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.